Back to
Erste Asset Management GmbH
HALO
Showing 8 of 30 quarters
Position history for
Erste Asset Management GmbH's holdings in Halozyme Therapeutics, Inc.
Yes. Erste Asset Management holds 34,800 shares of HALO (Halozyme Therapeutics), worth $2.7M, as of its Q2 2026 13F filing. It reduced the position by 76,500 shares (-68.7%) from Q1 2026. Erste Asset Management has held HALO in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$2.7M
Current Shares
34,800
Total Value Change
-$37,302
Total Shares Change
-13,000
Quarter-by-Quarter History